44
Views
6
CrossRef citations to date
0
Altmetric
Review Papers

Pathophysiology and Management of Post Resection Liver Failure

, , , , , , & show all
Pages 155-161 | Published online: 11 Mar 2016

References

  • Rahbari C. C., Garden O. J., Padbury R., Brooke-Smith M., Crawford M., Adam R. et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery, 2011, 149: 713–724.
  • Poon R. T., Fan S. T., Lo C. M., Liu C. L., Lam C. M., Yuen w. K. et al. Improving perioperative outcome expands the role of hepa-tectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg, 2004, 240: 698–708.
  • Belghiti J., Hiramatsu K., Benoist S., Massault P., Sauvanet A., Farges O. Seven hundred forty-seven hepatectomies in the, 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg, 2000, 191: 38–46.
  • Farges O., Malassagne B., Flejou J. F., Balzan S., Sauvanet A., Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg, 1999, 229: 210–215.
  • Jarnagin w. R., Gonen M., Fong Y., DeMatteo R. P., Ben- Porat L., Little S. et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg, 2002, 236: 397–406.
  • Laurent C., Sa Cunha A., Couderc P., Rullier E., Saric J. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg, 2003, 90: 1131–1136.
  • Detroz B., Sugarbaker P. H., Knol J. A., Petrelli C., Hughes K. S. Causes of death in patients undergoing liver surgery. Cancer Treatm Res, 1994, 69: 241–257.
  • Bolder u., Brune A., Schmidt S., Tacke J., Jauch K. w., Lohlein D. Preoperative assessment of mortality risk in hepatic resection by clinical variables: a multivariate analysis. Liver Transpl Surg, 1999, 5: 227–237.
  • Simmonds P. C., Primrose J. N., Colquitt J. L., Garden O. J., Poston G. J., Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer., 2006, 94: 982–999.
  • van den Broek M. A., Olde Damink S. w., Dejong C. H., Lang H., Malago M., Jalan R. et al. Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int, 2008, 28: 767–780.
  • Helling T. S. Liver failure following partial hepatectomy. HPB, 2006, 8: 165–174.
  • Balzan S., Belghiti J., Farges O., Ogata S., Sauvanet A., Delefosse D. et al. The “50–50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg, 2005, 242: 824–828.
  • Schindl M. J., Redhead D. N., Fearon K. C., Garden O. J., wigmore S. J., Edinburgh Liver S. et al. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut, 2005, 54: 289–296.
  • Taub R. Liver regeneration: from myth to mechanism. Nature reviews Molecular cell biology, 2004, 5: 836–847.
  • Garcea G., Maddern G. J. Liver failure after major hepatic resection. J Hep Bil Pancr Surg, 2009, 16: 145–155.
  • zimmers T. A., McKillop I. H., Pierce R. H., Yoo J. Y., Koniaris L. G. Massive liver growth in mice induced by systemic interleukin 6 administration. Hepatology, 2003, 38: 326–334.
  • Kin Y., Nimura Y., Hayakawa N., Kamiya J., Kondo S., Nagino M. et al. Doppler analysis of hepatic blood flow predicts liver dysfunction after major hepatectomy. W J Surg, 1994, 18: 143–149.
  • Demetris A. J., Kelly D. M., Eghtesad B., Fontes P., wallis Marsh J., Tom K. et al. Pathophysiologic observations and histo-pathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol, 2006, 30: 986–993.
  • Fukuchi T., Hirose H., Onitsuka A., Hayashi M., Senga S., Imai N. et al. Effects of portal-systemic shunt following 90% partial hepatectomy in rats. J Surg Res, 2000, 89: 126–131.
  • Yanaga K., Kishikawa K., Suehiro T., Nishizaki T., Shimada M., Itasaka H. et al. Partial hepatic grafting: porcine study on critical volume reduction. Surgery, 1995, 118: 486–492.
  • Man K., Lo e. M., Ng I. O., Wong Y. C., Qin L. F., Fan S. T. et al. Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg, 2001, 136: 280–285.
  • KiucHi T., Kasahara M., Uryuhara K., Inomata Y., üemoto S., Asonuma κ. et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation, 1999, 67: 321–327.
  • Ito K., Ozasa H., Horikawa S. Effects of prior splenectomy on remnant liver after partial hepatectomy with Pringle maneuver in rats. Liver Int, 2005, 25: 438–444.
  • Pawlik T. M., Schulick R. D., Choti M. A. Expanding criteria for resectability of colorectal liver metastases. Oncologist, 2008, 13: 51–64.
  • Schindl M., Wigmore S. J., Currie E. J., Laengle f., Garden O. J. Prognostic scoring in colorectal cancer liver metastases: development and validation. Arch Surg, 2005, 140: 183–189.
  • Tucker O. N., Heaton N. The ‘small for size’ liver syndrome. Cur Opin Crit Care, 2005, 11: 150–155.
  • Jaeschke H. Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastroint Liver Physiol, 2006, 290: G1083–G1088.
  • Abu-Amara M., Yang S. Y., Tapuria N., Fuller B., Davidson B., Seifalian a. Liver ischemia/reperfusion injury: processes in inflammatory networks - a review. Liver Transpl, 2010, 16: 1016–1032.
  • Selzner C., Rüdiger H., Graf R., Clavien P. A. Protective strategies against ischemic injury of the liver. Gastroenterology, 2003, 125: 917–936.
  • Gross K., Katz S., Dunn S. P., CiKRrr D., Rosenthal R., Grosfeld J. L. Bacterial clearance in the intact and regenerating liver. J Ped Surg, 1985, 20: 320–323.
  • Roelofsen H., van der Veere C. C., Ottenhoff R., Schoemaker B., Jansen P. L., Oude Elferink R. P. Decreased bilirubin transport in the perfused liver of endotoxemic rats. Gastroenterology, 1994, 107: 1075–1084.
  • Aκγγα K., Okuno M., Enya M., Imai S., Moriwaki H., Kawada C. et al. Impaired liver regeneration in mice by lipopolysaccharide via TNF-alpha/kallikrein-mediated activation of latent TGF-beta. Gastroenterology, 2002, 123: 352–364.
  • Nolan J. P. Endotoxin, reticuloendothelial function, and liver injury. Hepatology, 1981, 1: 458–465.
  • Selzner C., Selzner M., Odermatt B., Tian Y., Van Rooijen C., Clavien P. A. ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice. Gastroenterology, 2003, 124: 692–700.
  • Mochida S., Ogata I., Hirata K., Ohta Y., Yamada S., Fujiwara K. Provocation of massive hepatic necrosis by endotoxin after partial hepatectomy in rats. Gastroenterology, 1990, 99: 771–777.
  • Filos KS., Kirkilesis I., Spiliopoulou I., Scopa C. D., Nikolopoulou V., Kouraklis G. et al. Bacterial translocation, endotoxaemia and apoptosis following Pringle manoeuvre in rats. Injury, 2004, 35: 35–43.
  • Boermeester M. A., Houdijk A. P., Meyer S., Cuesta M. A., Appelmelk B. J., Wesdorp R. I. et al. Liver failure induces a systemic inflammatory response. Prevention by recombinant N-terminal bactericidal/permeability-increasing protein. Am J Pathol, 1995, 147: 1428–1440.
  • Hammond J. S., Guha I. C., Beckingham I. J., Lobo D. C. Prediction, prevention and management of postresection liver failure. Br J Surg, 2011, 98: 1188–1200.
  • Clavien P. A., Petrowsky H., DeOliveira M. L., Graf R. Strategies for safer liver surgery and partial liver transplantation. NEJM, 2007, 356: 1545–1559.
  • Poon R. T., Fan S. T. Assessment of hepatic reserve for indication of hepatic resection: how I do it. J Hep Bil Pancr Surg, 2005, 12: 31–37.
  • Gomez D., Malik H. घ., Bonney G. K., Wong v., Toogood G. J., Lodge J. P. et al. Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg, 2007, 94: 1395–1402.
  • Yeh M. M., Brunt E. M. Pathology of nonalcoholic fatty liver disease. Am J Clin Pathol, 2007, 128: 837–847.
  • de Meijer v. E., Kalish B. T., Puder M., Ijzermans J. C. Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg, 2010, 97: 1331–1339.
  • Mendes F. D., Suzuki A., Sanderson S. O., Lindor K. D., Angulo P. Prevalence and Indicators of Portal Hypertension in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol, 2012.
  • Selzner M., Clavien P. A. Fatty liver in liver transplantation and surgery. Sem Liv Dis, 2001, 21: 105–113.
  • Sano T., Ajiki T., Takeyama Y., Kuroda Y. Internal biliary drainage improves decreased number of gut mucosal T lymphocytes and MAdCAM-1 expression in jaundiced rats. Surgery, 2004, 136: 693–699.
  • Belghiti J., Ogata S. Preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma. HPB, 2005, 7: 252–253.
  • Khuntikeo C., Pugkhem A., Bhudhisawasdi v., Uttaravichien T. Major hepatic resection for hilar cholangiocarcinoma without preoperative biliary drainage. APJCP, 2008, 9: 83–85.
  • Laurent A., Tayar C., Cherqui D. Cholangiocarcinoma: preoperative biliary drainage (Con). HPB, 2008, 10: 126–129.
  • Nimura Y. Preoperative biliary drainage before resection for cholangiocarcinoma (Pro). HPB, 2008, 10: 130–133.
  • Kanda H., Nimura Y., Yasui A., Uematsu T., Kamiya S., Machiki Y. et al. Hepatic blood flow after acute biliary obstruction and drainage in conscious dogs. Hepatol Gastroenterol, 1996, 43: 235–240.
  • Baer H. υ., Guastella T., Wheatley A. M., Zimmermann A., Blumgart L. H. Acute effects of partial hepatectomy on liver blood flow in the jaundiced rat. J Hepatol, 1993, 19: 377–382.
  • Wang D. S., Dou K. F., Li K. Z., Gao घ. Q., Song Z. S., Liu Z. C. Hepatocellular apoptosis after hepatectomy in obstructive jaundice in rats. W Journ Gastroenterol, 2003, 9: 2737–2741.
  • Tracy T. F. Jr., Bailey P. v., Goerke M. E., Sotelo-Avila C., Weber T. R. Cholestasis without cirrhosis alters regulatory liver gene expression and inhibits hepatic regeneration. Surgery, 1991, 110: 176–182; discussion 82–83.
  • Nakano K., Chijiiwa K., Tanaka M. Lower activity of CCAAT/enhancer-binding protein and expression of cyclin E, but not cyclin D1, activating protein-1 and p21(WAF1), after partial hepatectomy in obstructive jaundice. Biochem Biophys Res Com, 2001, 280: 640–645.
  • Chun Y. S., Laurent A., Maru D., vauthey J. N. Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases. Lancet Oncol, 2009, 10: 278–286.
  • vauthey J. C., Pawlik T. M., Ribero D., Wu T. T., Zorzi D., Hoff P. M. et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol, 2006, 24: 2065–2072.
  • Adam R., Delvart v., Pascal G., valeanu A., Castaing D., Azoulay D. et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict longterm survival. Ann Surg, 2004, 240: 644–657.
  • Nakano H., Oussoultzoglou E., Rosso E., Casnedi S., Chenard- Neu M. P., Dufour P. et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg, 2008, 247: 118–124.
  • Karoui M., Penna C., Amin-Hashem M., MrrRY E., Benoist S., Franc B. et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg, 2006, 243: 1–7.
  • Aloysius M. M., Zaitoun A. M., Beckingham I. J., Neal K. R., Aithal g. p., Bessell e. M. et al. The pathological response to neoadjuvant chemotherapy with FOLFOX-4 for colorectal liver metastases: a comparative study. Virch Archiv, 2007, 451: 943948.
  • Little S. A., Jarnagin W. R., DeMatteo R. P., Blumgart L. H., Fong Y. Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastroint Surg, 2002, 6: 88–94.
  • Sass D. A., Chang P., Chopra K. B. Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci, 2005, 50: 171–180.
  • Balzan S., Nagarajan G., Farges O., Galleano C. Z., Dokmak S., Paugam C. et al. Safety of liver resections in obese and overweight patients. W Journ Surg, 2010, 34: 2960–2968.
  • Bozzetti F. Rationale and indications for preoperative feeding of malnourished surgical cancer patients. Nutrition, 2002, 18: 953959.
  • Fan S. T., Lo C. M., Lai E. C., Chu K. M., Liu C. L., Wong J. Perioperative nutritional support in patients undergoing hepatec-tomy for hepatocellular carcinoma. The New England journal of medicine, 1994, 331: 1547–1552.
  • Awad S., Constantin-Teodosiu D., Macdonald ड. A., Lobo D. N. Short-term starvation and mitochondrial dysfunction - a possible mechanism leading to postoperative insulin resistance. Clin Nutr, 2009, 28: 497–509.
  • Ikegami T., Nishizaki T., Yanaga K., Shimada M., Kishikawa K., Nomoto K. et al. The impact of donor age on living donor liver transplantation. Transplantation, 2000, 70: 1703–1707.
  • Tietz N. W., Shuey D. F., Wekstein D. R. Laboratory values in fit aging individuals - sexagenarians through centenarians. Clin Chem, 1992, 38: 1167–1185.
  • Tsukamoto I., Nakata R., Kojo S. Effect of ageing on rat liver regeneration after partial hepatectomy. Biochem Mol Biol Int, 1993, 30: 773–778.
  • Beyer HS., Sherman R., Zieve L. Aging is associated with reduced liver regeneration and diminished thymidine kinase mRNA content and enzyme activity in the rat. J Lab Clin Med, 1991, 117: 101–108.
  • Mullen J. T., Ribero D., Reddy S. K., Donadon M., Zorzi D., Gautam S. et al. Hepatic insufficiency and mortality in 1,059 non-cirrhotic patients undergoing major hepatectomy. J Am Col Surg, 2007, 204: 854–862.
  • Shoup M., Gonen M., D’Angelica M., Jarnagin W. R., DeMatteo R. P., Schwartz L. H. et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg, 2003, 7: 325–330.
  • Yokoyama Y., Schwacha M. G., Samy T. S., Bland K. I., Chaudry I. H. Gender dimorphism in immune responses following trauma and hemorrhage. Immunol Res, 2002, 26: 63–76.
  • Sarmiento J. M., Bower T. C., Cherry K. J., Farnell M. B., Nagorney D. M. Is combined partial hepatectomy with segmental resection of inferior vena cava justified for malignancy ? Arch Surg, 2003, 138: 624–630.
  • Lodge J. P., Ammori B. J., Prasad K. R., Bellamy M. C. Ex vivo and in situ resection of inferior vena cava with hepatectomy for colorectal metastases. Ann Surg, 2000, 231: 471–479.
  • Azoulay D., Andreani P., Maggi u., Salloum C., Perdigão F., Sebagh M. et al. Combined liver resection and reconstruction of the supra-renal vena cava: the Paul Brousse experience. Ann Surg, 2006, 244: 80–88.
  • Man K., Fan S. T., Ng I. O., Lo C. M., Liu C. L., Wong J. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg, 1997, 226: 704711.
  • Belghiti J., Noun R., Malafosse R., Jagot P., Sauvanet A., Pierangeli F. et al. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg, 1999, 229: 369–375.
  • Liu C. L., Fan S. T., Cheung S. T., Lo C. M., Ng I. O., Wong J. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg, 2006, 244: 194–203.
  • Abulkhir A., Limongelli P., Healey A. J., Damrah O., Tait P., Jackson J. et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg, 2008, 247: 49–57.
  • Adam R., Laurent A., Azoulay D., Castaing D., Bismuth H. Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg, 2000, 232: 777–785.
  • Belli G., Fantini C., D’Agostino A., Cioffi L., Langella S., RussoLiLLO N. et al. Laparoscopic versus open liver resection for hepatocellular carcinoma in patients with histologically proven cirrhosis: short-and middle-term results. Surg Endosc, 2007, 21: 2004–2011.
  • Hodgson W. J., Morgan J., Byrne D., DelGuercio L. R. Hepatic resections for primary and metastatic tumors using the ultrasonic surgical dissector. AM J Surg, 1992, 163: 246–250.
  • Imamura H., Seyama Y., Kokudo N., Maema A., Sugawara Y., Sano K. et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg, 2003, 138: 1198–1206; discussion 206.
  • Jensen L. S., Andersen A. J., Christiansen P. M., Hokland P., Juhl C. O., Madsen G. et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg, 1992, 79: 513516.
  • Dellinger R. P., Carlet J. M., Masur H., Gerlach H., Calandra T., Cohen J. et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med, 2004, 32: 858–873.
  • Wu C. C., Yeh D. C., Lin M. C., Liu T. J., P’Eng F. K. Prospective randomized trial of systemic antibiotics in patients undergoing liver resection. Br J Surg, 1998, 85: 489–493.
  • Rolando N., Gimson A., Wade J., Philpott-Howard J., Casewell M., Williams R. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology, 1993, 17: 196–201.
  • van de Kerkhove M. P., de Jong K. P., Rijken A. M., de Pont A. C., van Gulik T. M. MARS treatment in posthepatectomy liver failure. Liver Int, 2003, 23: 44–51.
  • Kellersmann R., Gassel H. J., Buhler C., Thiede A., Timmermann W. Application of Molecular Adsorbent Recirculating System in patients with severe liver failure after hepatic resection or transplantation: initial single-centre experiences. Liver, 2002, 22: 56–58.
  • Rittler P., Ketscher C., Inthorn D., Jauch K. W., Hartl W. H. Use of the molecular adsorbent recycling system in the treatment of postoperative hepatic failure and septic multiple organ dysfunction - preliminary results. Liver Int, 2004, 24: 136–141.
  • Otsuka Y., Duffy J. P., Saab S., Farmer D. G., Ghobrial R. M., Hiatt J. R. et al. Postresection hepatic failure: successful treatment with liver transplantation. Liver Transpl, 2007, 13: 672–679.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.